Upgrade to SI Premium - Free Trial

Eloxx Pharmaceuticals (ELOX)

13.03 -0.97 (6.93%)

Chart
Today 6M 1Y 5Y

Latest Headlines

Form SCHEDULE 13G Eloxx Pharmaceuticals, Filed by: Coastlands Capital LP June 17, 2026 7:16 PM - SEC Filing Form SCHEDULE 13G Eloxx Pharmaceuticals, Filed by: Domicilium Real Estate Fund III LP June 17, 2026 5:18 PM - SEC Filing Form 4 Eloxx Pharmaceuticals, For: Jun 10 Filed by: Domicilium Real Estate Fund III LP June 17, 2026 5:15 PM - SEC Filing Form 3 Eloxx Pharmaceuticals, For: Jun 05 Filed by: Domicilium Real Estate Fund III LP June 17, 2026 5:11 PM - SEC Filing Form SCHEDULE 13G Eloxx Pharmaceuticals, Filed by: EcoR1 Capital, LLC June 16, 2026 7:11 PM - SEC Filing Form SCHEDULE 13G Eloxx Pharmaceuticals, Filed by: Stonepine Capital Management, LLC June 16, 2026 6:05 PM - SEC Filing Form SCHEDULE 13G Eloxx Pharmaceuticals, Filed by: Invus Global Management, LLC June 15, 2026 6:02 PM - SEC Filing Form 4 Eloxx Pharmaceuticals, For: Jun 08 Filed by: Kjellson Nina S June 10, 2026 8:01 PM - SEC Filing Form 4 Eloxx Pharmaceuticals, For: Jun 08 Filed by: Walts Alan Edmund June 10, 2026 8:01 PM - SEC Filing Form 4 Eloxx Pharmaceuticals, For: Jun 08 Filed by: Webster Stephen W June 10, 2026 8:01 PM - SEC Filing Form 4 Eloxx Pharmaceuticals, For: Jun 10 Filed by: Aggarwal Sumit June 10, 2026 8:01 PM - SEC Filing Form 4 Eloxx Pharmaceuticals, For: Jun 08 Filed by: Rubin Steven D June 10, 2026 8:01 PM - SEC Filing Eloxx Pharmaceuticals prices $66 million offering, uplists to NASDAQ June 8, 2026 9:24 PM - StreetInsider Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq June 8, 2026 9:24 PM - PR NewsWire Form 4 Eloxx Pharmaceuticals, For: May 27 Filed by: Domicilium Real Estate Fund III LP June 5, 2026 10:45 AM - SEC Filing Form 8-A12B Eloxx Pharmaceuticals, June 1, 2026 5:26 PM - SEC Filing Form S-1/A Eloxx Pharmaceuticals, June 1, 2026 4:56 PM - SEC Filing Form 8-K Eloxx Pharmaceuticals, For: May 27 June 1, 2026 7:00 AM - SEC Filing Form 3 Eloxx Pharmaceuticals, For: May 27 Filed by: Webster Stephen W June 1, 2026 7:00 AM - SEC Filing Form 3 Eloxx Pharmaceuticals, For: May 27 Filed by: Kjellson Nina S June 1, 2026 7:00 AM - SEC Filing Form 4 Eloxx Pharmaceuticals, For: May 27 Filed by: Coastlands Capital LP May 29, 2026 9:56 PM - SEC Filing Form SCHEDULE 13G/A Eloxx Pharmaceuticals, Filed by: Coastlands Capital LP May 29, 2026 9:55 PM - SEC Filing Form 4 Eloxx Pharmaceuticals, For: Sep 19 Filed by: Rubin Steven D May 8, 2026 5:12 PM - SEC Filing Form 4 Eloxx Pharmaceuticals, For: Feb 06 Filed by: Aggarwal Sumit May 8, 2026 4:54 PM - SEC Filing Form 4 Eloxx Pharmaceuticals, For: Sep 19 Filed by: Walts Alan Edmund May 8, 2026 4:45 PM - SEC Filing Form DEF 14C Eloxx Pharmaceuticals, For: May 08 May 8, 2026 4:27 PM - SEC Filing Form S-1 Eloxx Pharmaceuticals, May 7, 2026 4:57 PM - SEC Filing Form 10-Q Eloxx Pharmaceuticals, For: Mar 31 May 5, 2026 6:06 AM - SEC Filing Form 3 Eloxx Pharmaceuticals, For: Apr 28 Filed by: Domicilium Real Estate Fund III LP May 4, 2026 6:26 PM - SEC Filing Form SCHEDULE 13G Eloxx Pharmaceuticals, Filed by: Domicilium Real Estate Fund III LP May 4, 2026 6:18 PM - SEC Filing Form SCHEDULE 13G Eloxx Pharmaceuticals, Filed by: Coastlands Capital LP May 1, 2026 9:55 PM - SEC Filing Form 3 Eloxx Pharmaceuticals, For: Apr 27 Filed by: Coastlands Capital LP May 1, 2026 9:45 PM - SEC Filing Form 8-K Eloxx Pharmaceuticals, For: Apr 28 May 1, 2026 4:06 PM - SEC Filing Form PRE 14C Eloxx Pharmaceuticals, For: Apr 28 April 28, 2026 5:24 PM - SEC Filing Full Article List